Skip to content

Line Blot Immunoassay for Antibodies to Borrelia burgdorferi (Lyme Disease Antibody Screening)

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies in your blood that may indicate exposure to *Borrelia burgdorferi*, the bacterium responsible for Lyme disease, often spread through tick bites.

Quick summary

["A simple blood test to check for Lyme disease antibodies, helping identify possible exposure."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
101218-6
Short code
H dobrava IgM SerPl Ql Line blot
Synonyms
H dobrava IgM SerPl Ql Line blot
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The line blot immunoassay identifies specific antibodies your immune system produces in response to *Borrelia burgdorferi*. If antibodies are present, it suggests past or current infection. This test uses a qualitative method to detect multiple related antigens from the bacterium.

How the Test Works

Your blood sample is tested on a membrane with specific antigens. If antibodies bind to these antigens, they create visible lines, confirming potential exposure. This method is quick and often used as an initial screening tool.

When You Might Need This Test

Your healthcare provider may recommend this test if you have symptoms like fever, fatigue, joint pain, or a rash (e.g., bull’s-eye rash) after a tick bite, especially in areas where Lyme disease is common.

What to Expect Before the Test

No special preparation is needed. You’ll have a simple blood draw, usually from your arm, and the results are typically available within a few days.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Positive results suggest possible Lyme disease exposure but do not confirm infection alone. Follow-up testing (e.g., ELISA or Western blot) may be needed for diagnosis. Early detection is important for treatment, which can help prevent long-term complications.

Short name

Lyme Disease Antibody Screen (Line Blot)

Frequently asked questions

Why was this test ordered?
Your doctor may have ordered this test to check for Lyme disease antibodies if you’ve had symptoms or a tick bite in a risk area, or if you’re being evaluated for unexplained symptoms like joint pain or fatigue.
What does a positive result mean?
A positive result indicates your body may have produced antibodies against *Borrelia burgdorferi*, suggesting possible exposure. However, it doesn’t confirm Lyme disease without further testing. Consult your doctor for next steps.
Do I need to take any special steps if my results are positive?
If your test is positive, your doctor will likely order additional tests (like ELISA or Western blot) to confirm Lyme disease. Follow their guidance for treatment or further evaluation, especially if you have symptoms like rash, joint pain, or neurological issues.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy